Document Detail

Biodistribution and catabolism of 18F-labeled N-epsilon-fructoselysine as a model of Amadori products.
MedLine Citation:
PMID:  17045166     Owner:  NLM     Status:  MEDLINE    
Amadori products are formed in the early stage of the so-called Maillard reaction between reducing sugars and amino acids or proteins. Such nonenzymatic glycosylation may occur during the heating or storage of foods, but also under physiological conditions. N-epsilon-fructoselysine is formed via this reaction between the epsilon-amino group of peptide-bound lysine and glucose. Despite the fact that, in certain heated foods, up to 50% of lysyl moieties may be modified to such lysine derivatives, up to now, very little is known about the metabolic fate of alimentary administered Amadori compounds. In the present study, N-succinimidyl-4-[18F]fluorobenzoate was used to modify N-epsilon-fructoselysine at the alpha-amino group of the lysyl moiety. The in vitro stability of the resulting 4-[18F]fluorobenzoylated derivative was tested in different tissue homogenates. Furthermore, the 4-[18F]fluorobenzoylated N-epsilon-fructoselysine was used in positron emission tomography studies, as well as in studies concerning biodistribution and catabolism. The results show that the 4-[18F]fluorobenzoylated N-epsilon-fructoselysine is phosphorylated in vitro, as well as in vivo. This phosphorylation is caused by fructosamine 3-kinases and occurs in vivo, particularly in the kidneys. Despite the action of these enzymes, it was shown that a large part of the intravenously applied radiolabeled N-epsilon-fructoselysine was excreted nearly unchanged in the urine. Therefore, it was concluded that the predominant part of peptide-bound lysine that was fructosylated during food processing is not available for nutrition.
Christina Hultsch; Michael Hellwig; Beate Pawelke; Ralf Bergmann; Katrin Rode; Jens Pietzsch; René Krause; Thomas Henle
Related Documents :
9169676 - Reports on contrast media reactions: analysis of data from reports to the u.s. food and...
18547626 - Use of multiple doses of epinephrine in food-induced anaphylaxis in children.
16223686 - A comparative study and development of an improved method for the reduction of nitroare...
106746 - Oral cromoglycate: its value in the treatment of adverse reactions to foods.
6486936 - Tsetse fly feeding preference as determined by vehicular trapping in tanzania.
24794076 - Loss of migration and urbanization in birds: a case study of the blackbird (turdus meru...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nuclear medicine and biology     Volume:  33     ISSN:  0969-8051     ISO Abbreviation:  Nucl. Med. Biol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-18     Completed Date:  2007-01-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9304420     Medline TA:  Nucl Med Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  865-73     Citation Subset:  IM    
Institute of Radiopharmacy, Research Center Rossendorf, P.O. Box 51 01 19, D-01314 Dresden, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fluorine Radioisotopes / diagnostic use,  pharmacokinetics
Lysine / analogs & derivatives*,  diagnostic use,  pharmacokinetics
Maillard Reaction*
Metabolic Clearance Rate
Organ Specificity
Positron-Emission Tomography
Radiopharmaceuticals / diagnostic use,  pharmacokinetics
Rats, Wistar
Tissue Distribution
Reg. No./Substance:
0/Fluorine Radioisotopes; 0/Radiopharmaceuticals; 21291-40-7/fructosyl-lysine; 56-87-1/Lysine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Visualizing pancreatic beta-cell mass with [11C]DTBZ.
Next Document:  Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene...